Indivior Pharmaceuticals, Inc. Common Stock (INDV) Financials
Key financial figures for Indivior Pharmaceuticals, Inc. Common Stock (Q2 2026).
- Revenue
- $343M
- Net Income
- $122M
- EPS
- $1.02
- Total Assets
- $1.2B
- Operating Cash Flow
- $229M
Full income statement, balance sheet, and cash flow for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.